<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37239263</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3425</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>12</Day></PubDate></JournalIssue><Title>Brain sciences</Title><ISOAbbreviation>Brain Sci</ISOAbbreviation></Journal><ArticleTitle>Effects of Multidisciplinary Rehabilitation Enhanced with Neuropsychological Treatment on Post-Acute SARS-CoV-2 Cognitive Impairment (Brain Fog): An Observational Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">791</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/brainsci13050791</ELocationID><Abstract><AbstractText>Concentration and memory impairment (named "brain fog") represents a frequent and disabling neuropsychological sequela in post-acute COVID-19 syndrome (PACS) patients. The aim of this study was to assess whether neurocognitive function could improve after a multidisciplinary rehabilitation program enhanced with individualized neuropsychological treatment. A prospective monocentric registry of PACS patients consecutively admitted to our Rehabilitation Unit was created. The Montreal Cognitive Assessment (MoCA) was used to assess cognitive impairment at admission and discharge. A total of sixty-four (64) PACS patients, fifty-six (56) of them with brain fog, were treated with a day-by-day individualized psychological intervention of cognitive stimulation (45 min) on top of a standard in-hospital rehabilitation program. The mean duration of the acute-phase hospitalization was 55.8 &#xb1; 25.8 days and the mean in-hospital rehabilitation duration was 30 &#xb1; 10 days. The mean age of the patients was 67.3 &#xb1; 10.4 years, 66% of them were male, none had a previous diagnosis of dementia, and 66% of the entire sample had experienced severe COVID-19. At admission, only 12% of the patients had normal cognitive function, while 57% showed mild, 28% moderate, and 3% severe cognitive impairment. After psychological treatment, a significant improvement in the MoCA score was found (20.4 &#xb1; 5 vs. 24.7 &#xb1; 3.7; <i>p</i> &lt; 0.0001) as a result of significant amelioration in the following domains: attention task (<i>p</i> = 0.014), abstract reasoning (<i>p</i> = 0.003), language repetition (<i>p</i> = 0.002), memory recall (<i>p</i> &lt; 0.0001), orientation (<i>p</i> &lt; 0.0001), and visuospatial abilities (<i>p</i> &lt; 0.0001). Moreover, the improvement remained significant after multivariate analysis adjusted for several confounding factors. Finally, at discharge, 43% of the patients with cognitive impairment normalized their cognitive function, while 4.7% were discharged with residual moderate cognitive impairment. In conclusion, our study provides evidence of the effects of multidisciplinary rehabilitation enhanced with neuropsychological treatment on improvement in the cognitive function of post-acute COVID-19 patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rabaiotti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cirac&#xec;</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3887-9295</Identifier><AffiliationInfo><Affiliation>Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donelli</LastName><ForeName>Davide</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7895-2840</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, University Hospital of Parma, University of Parma, Viale Antonio Gramsci, 14, 43126 Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oggioni</LastName><ForeName>Carlotta</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzi</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savi</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonelli</LastName><ForeName>Michele</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5941-6604</Identifier><AffiliationInfo><Affiliation>Department of Public Health, AUSL-IRCCS of Reggio Emilia, Via Amendola, 42122 Reggio Emilia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzato</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0316-257X</Identifier><AffiliationInfo><Affiliation>"Humandive", Piazzale XX Settembre, 1/B, 33170 Pordenone, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moderato</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiology Department, "Guglielmo da Saliceto" Hospital, Via Taverna Giuseppe, 49, 29121 Piacenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brambilla</LastName><ForeName>Valerio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziveri</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brambilla</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRCCS Fondazione Don Carlo Gnocchi, Via Carlo Girola, 30, 20162 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bini</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nouvenne</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>U.O. Medicina Interna di Continuit&#xe0;, Azienda Ospedaliero-Universit&#xe0; di Parma, Via Gramsci, 14, 43126 Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazzeroni</LastName><ForeName>Davide</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9171-118X</Identifier><AffiliationInfo><Affiliation>Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Brain Sci</MedlineTA><NlmUniqueID>101598646</NlmUniqueID><ISSNLinking>2076-3425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuropsychology</Keyword><Keyword MajorTopicYN="N">rehabilitation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37239263</ArticleId><ArticleId IdType="pmc">PMC10216015</ArticleId><ArticleId IdType="doi">10.3390/brainsci13050791</ArticleId><ArticleId IdType="pii">brainsci13050791</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., Dong W. Clinical Sequelae of COVID-19 Survivors in Wuhan, China: A Single-Centre Longitudinal Study. Clin. Microbiol. Infect. 2021;27:89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedberg P., Granath F., Bruchfeld J., Askling J., Sj&#xf6;holm D., Fored M., F&#xe4;rnert A., Naucler P. Post COVID-19 Condition Diagnosis: A Population-Based Cohort Study of Occurrence, Associated Factors, and Healthcare Use by Severity of Acute Infection. J. Intern. Med. 2023;293:246&#x2013;258. doi: 10.1111/joim.13584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13584</ArticleId><ArticleId IdType="pmc">PMC9877994</ArticleId><ArticleId IdType="pubmed">36478477</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-Covid Syndrome in Individuals Admitted to Hospital with COVID-19: Retrospective Cohort Study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J., Msika E.-F., Queneau M., Farid K., Paquet C. Long COVID: Cognitive Complaints (brain Fog) and Dysfunction of the Cingulate Cortex. J. Neurol. 2022;269:44&#x2013;46. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Long COVID Syndrome-Associated Brain Fog. J. Med. Virol. 2022;94:979&#x2013;984. doi: 10.1002/jmv.27404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Sia A.L.-S., Neo J.E., Jen-Wei Tan B., Tan E.-K. &#x201c;Brain Fog&#x201d; and COVID-19. Am. J. Med. Sci. 2023;365:472&#x2013;474. doi: 10.1016/j.amjms.2023.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2023.01.003</ArticleId><ArticleId IdType="pmc">PMC9827745</ArticleId><ArticleId IdType="pubmed">36632867</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.-H., Wood J., O&#x2019;Dea M.R., Dutton S., Shamardani K., Nwangwu K., et al. Mild Respiratory COVID Can Cause Multi-Lineage Neural Cell and Myelin Dysregulation. Cell. 2022;185:2452&#x2013;2468.e16. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson E.M., Nagaraja S., Ocampo A., Tam L.T., Wood L.S., Pallegar P.N., Greene J.J., Geraghty A.C., Goldstein A.K., Ni L., et al. Methotrexate Chemotherapy Induces Persistent Tri-Glial Dysregulation That Underlies Chemotherapy-Related Cognitive Impairment. Cell. 2019;176:43&#x2013;55.e13. doi: 10.1016/j.cell.2018.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.10.049</ArticleId><ArticleId IdType="pmc">PMC6329664</ArticleId><ArticleId IdType="pubmed">30528430</ArticleId></ArticleIdList></Reference><Reference><Citation>Manly J.J., Tang M.-X., Schupf N., Stern Y., Vonsattel J.-P.G., Mayeux R. Frequency and Course of Mild Cognitive Impairment in a Multiethnic Community. Ann. Neurol. 2008;63:494&#x2013;506. doi: 10.1002/ana.21326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21326</ArticleId><ArticleId IdType="pmc">PMC2375143</ArticleId><ArticleId IdType="pubmed">18300306</ArticleId></ArticleIdList></Reference><Reference><Citation>Creamer M., Bell R., Failla S. Psychometric Properties of the Impact of Event Scale&#x2014;Revised. Behav. Res. Ther. 2003;41:1489&#x2013;1496. doi: 10.1016/j.brat.2003.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brat.2003.07.010</ArticleId><ArticleId IdType="pubmed">14705607</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 1983;67:361&#x2013;370. doi: 10.1111/j.1600-0447.1983.tb09716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y., Lee W.Y., Basri N.A., Collinson S.L., Merchant R.A., Venketasubramanian N., Chen C.L.-H. The Montreal Cognitive Assessment Is Superior to the Mini-Mental State Examination in Detecting Patients at Higher Risk of Dementia. Int. Psychogeriatr. 2012;24:1749&#x2013;1755. doi: 10.1017/S1041610212001068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610212001068</ArticleId><ArticleId IdType="pubmed">22687278</ArticleId></ArticleIdList></Reference><Reference><Citation>Centorbi C.S., Garau E., Borsi L., Brambilla V., Brambilla L., Lazzeroni D. New Insights on Cardiomyopathy. IntechOpen; London, UK: 2022. Cardiovascular Post-Acute COVID-19 Syndrome: Definition, Clinical Scenarios, Diagnosis, and Management.</Citation></Reference><Reference><Citation>Moderato L., Monello A., Lazzeroni D., Binno S., Giacalone R., Ferraro S., Piepoli M.F., Villani G.Q. Takotsubo syndrome during SARS-CoV-2 pneumonia: A possible cardiovascular complication. G. Ital. Cardiol. 2020;21:417&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">32425184</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzeroni D., Concari P., Moderato L. Simultaneous COVID-19 in Monozygotic Twins. Ann. Intern. Med. 2021;174:717&#x2013;719. doi: 10.7326/L20-1207.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L20-1207</ArticleId><ArticleId IdType="pmc">PMC7756243</ArticleId><ArticleId IdType="pubmed">33284682</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major Findings, Mechanisms and Recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B., Larson C., Hammond T.C., Oronsky A., Kesari S., Lybeck M., Reid T.R. A Review of Persistent Post-COVID Syndrome (PPCS) Clin. Rev. Allergy Immunol. 2023;64:66&#x2013;74. doi: 10.1007/s12016-021-08848-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopa&#x144;ska M., Ochojska D., Muchacka R., Dejnowicz-Velitchkov A., Bana&#x15b;-Z&#x105;bczyk A., Szczygielski J. Comparison of QEEG Findings before and after Onset of Post-COVID-19 Brain Fog Symptoms. Sensors. 2022;22:6606. doi: 10.3390/s22176606.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s22176606</ArticleId><ArticleId IdType="pmc">PMC9460343</ArticleId><ArticleId IdType="pubmed">36081063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J. Long-COVID: Cognitive Deficits (brain Fog) and Brain Lesions in Non-Hospitalized Patients. Presse Med. 2022;51:104090. doi: 10.1016/j.lpm.2021.104090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2021.104090</ArticleId><ArticleId IdType="pmc">PMC8552626</ArticleId><ArticleId IdType="pubmed">34718113</ArticleId></ArticleIdList></Reference><Reference><Citation>Callan C., Ladds E., Husain L., Pattinson K., Greenhalgh T. I Can&#x2019;t Cope with Multiple Inputs&#x2019;: A Qualitative Study of the Lived Experience of &#x201c;Brain Fog&#x201d; after COVID-19. BMJ Open. 2022;12:e056366. doi: 10.1136/bmjopen-2021-056366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-056366</ArticleId><ArticleId IdType="pmc">PMC8844964</ArticleId><ArticleId IdType="pubmed">35149572</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 Is Associated with Changes in Brain Structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Rodr&#xed;guez-Jim&#xe9;nez J., Palacios-Ce&#xf1;a M., de-la-Llave-Rinc&#xf3;n A.I., Fuensalida-Novo S., Florencio L.L., Ambite-Quesada S., Ortega-Santiago R., Arias-Bur&#xed;a J.L., Liew B.X.W., et al. Psychometric Properties of the Hospital Anxiety and Depression Scale (HADS) in Previously Hospitalized COVID-19 Patients. Int. J. Environ. Res. Public Health. 2022;19:9273. doi: 10.3390/ijerph19159273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19159273</ArticleId><ArticleId IdType="pmc">PMC9367824</ArticleId><ArticleId IdType="pubmed">35954630</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni D., Bai F., Castoldi R., Barbanotti D., Falcinella C., Mul&#xe8; G., Mondatore D., Tavelli A., Vegni E., Marchetti G., et al. Anxiety and Depression Symptoms after Virological Clearance of COVID-19: A Cross-Sectional Study in Milan, Italy. J. Med. Virol. 2021;93:1175&#x2013;1179. doi: 10.1002/jmv.26459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26459</ArticleId><ArticleId IdType="pmc">PMC7461061</ArticleId><ArticleId IdType="pubmed">32841387</ArticleId></ArticleIdList></Reference><Reference><Citation>Aljaberi M.A., Lee K.-H., Alareqe N.A., Qasem M.A., Alsalahi A., Abdallah A.M., Noman S., Al-Tammemi A.B., Mohamed Ibrahim M.I., Lin C.-Y. Rasch Modeling and Multilevel Confirmatory Factor Analysis for the Usability of the Impact of Event Scale-Revised (IES-R) during the COVID-19 Pandemic. Healthcare. 2022;10:1858. doi: 10.3390/healthcare10101858.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10101858</ArticleId><ArticleId IdType="pmc">PMC9602035</ArticleId><ArticleId IdType="pubmed">36292305</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemanno F., Houdayer E., Parma A., Spina A., Del Forno A., Scatolini A., Angelone S., Brugliera L., Tettamanti A., Beretta L., et al. COVID-19 Cognitive Deficits after Respiratory Assistance in the Subacute Phase: A COVID-Rehabilitation Unit Experience. PLoS ONE. 2021;16:e0246590. doi: 10.1371/journal.pone.0246590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246590</ArticleId><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>Albu S., Rivas Zozaya N., Murillo N., Garc&#xed;a-Molina A., Figueroa Chac&#xf3;n C.A., Kumru H. Multidisciplinary Outpatient Rehabilitation of Physical and Neurological Sequelae and Persistent Symptoms of COVID-19: A Prospective, Observational Cohort Study. Disabil. Rehabil. 2022;44:6833&#x2013;6840. doi: 10.1080/09638288.2021.1977398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2021.1977398</ArticleId><ArticleId IdType="pubmed">34559592</ArticleId></ArticleIdList></Reference><Reference><Citation>Prestia A., Caroli A., van der Flier W.M., Ossenkoppele R., Van Berckel B., Barkhof F., Teunissen C.E., Wall A.E., Carter S.F., Sch&#xf6;ll M., et al. Prediction of Dementia in MCI Patients Based on Core Diagnostic Markers for Alzheimer Disease. Neurology. 2013;80:1048&#x2013;1056. doi: 10.1212/WNL.0b013e3182872830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182872830</ArticleId><ArticleId IdType="pubmed">23390179</ArticleId></ArticleIdList></Reference><Reference><Citation>Handels R.L.H., Vos S.J.B., Kramberger M.G., Jelic V., Blennow K., van Buchem M., van der Flier W., Freund-Levi Y., Hampel H., Olde Rikkert M., et al. Predicting Progression to Dementia in Persons with Mild Cognitive Impairment Using Cerebrospinal Fluid Markers. Alzheimers. Dement. 2017;13:903&#x2013;912. doi: 10.1016/j.jalz.2016.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.12.015</ArticleId><ArticleId IdType="pubmed">28216393</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>